AI based diagnosis and treatment strategy of pulmonary lymphoepithelioma like carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036904

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary lymphoepithelioma-like carcinoma

Interventions

Lung lymphoepithelioma-like carcinoma group:no

thymic lymphoepithelioma-like carcinoma group:no

Nasopharyngeal carcinoma group:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung lymphoepithelioma-like carcinoma, thymic lymphoepithelioma-like carcinoma and nasopharyngeal carcinoma with complete follow-up cases underwent surgery from January 2010 to June 2020.

Exclusion criteria

Exclusion criteria: Cancer exclude lymphoepithelioma like carcinoma.

Design outcomes

Primary

Measure	Time frame
Histology image annotation;genomic mutation data;Tumor microenvironment data;	—

Countries

China

Contacts

Public ContactHan Yuchen

Shanghai Chest Hospital

2303894233@qq.com+86 18017327736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026